Simple Summary Radioactive iodine treatment is the oldest targeted therapy for
differentiated thyroid cancer. It can be used for normal thyroid remnant ablation (in order to …

Purpose We performed a systematic review and a meta-analysis to investigate the
successful ablation rate after radioiodine (RAI) administration in patients with differentiated …

Although circular RNAs (circRNAs) are involved in cell proliferation, differentiation,
apoptosis, and invasion, the underlying regulatory mechanisms of circRNAs in thyroid …

Background Many patients with papillary thyroid cancer (PTC) demonstrate satisfactory
outcomes. However, 8%–28% of patients with PTC show tumor recurrence, which may affect …

Objective This retrospective study aims to evaluate the therapeutic effect of varying dosages
of adjuvant radioactive iodine (RAI) therapy on intermediate-risk papillary thyroid carcinoma …

Background Multiple studies have established a strong relationship between circRNA and
cancer progression. Cervical lymph node metastasis is a key factor influencing the surgical …

Introduction Lymph node metastasis in patients with papillary thyroid carcinoma (PTC) is
associated with postoperative recurrence. Recently, most studies have focused on the …

Simple Summary Tumor recurrence is a relatively common event in papillary thyroid cancer
(PTC). The aim of this study was to analyze the time-varying pattern of recurrence in PTC …

Abstract Lysophosphatidic acid receptor 5 (LPAR5) is involved in mediating thyroid cancer
progression, but the underlying mechanism needs to be further revealed. In this study, we …

Purpose Generally, the prognosis for papillary thyroid cancer (PTC) is favorable. However,
the moderate risk involved warrants further evaluation. Hence, we investigated the clinical …